CANCER waiting times have reached unprecedented highs, fanning concerns survival rates could soon start receding. Few drugs, however, have managed to curb the spread of the disease to date. Now, a new study has suggested a commonly prescribed drug could be instrumental in the war on cancer.
Daily Express :: Health Feed
